Oral administration of LGG-JP significantly enhanced the effect of cancer vaccine in inhibiting tumor growth (Figure 3B), as well as an enhanced the proportion of CD4+ T cells and CD8+ T cells infiltration in tumor microenvironment (Figure 3E, F). This evidence concerns the gene CD8A and cancer.